Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.06%
SPX
+0.17%
IXIC
+0.54%
FTSE
+0.14%
N225
+1.45%
AXJO
-0.24%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

ENSG is now overvalued and could go down -25%

Jan 12, 2025, 1:00 PM
-1.31%
What does ENSG do
The Ensign Group, headquartered in San Juan Capistrano, California, provides skilled nursing and rehabilitative care services through 312 facilities across 13 states and employs 35,300 people. The company went public on November 12, 2007, and operates in two segments: Skilled Services and Standard Bearer.
Based on our analysis, Ensign Group has received an overvalued rating of 2 out of 5 stars from Cashu. This assessment is primarily driven by its higher valuation ratios compared to the sector averages, indicating potential concerns about its current market price relative to its financial performance. The Price-to-Earnings (PE) Ratio for Ensign Group stands at 31.27, significantly higher than the sector average of 15.20. A high PE ratio suggests that investors are paying more for each dollar of earnings, which could indicate overvaluation if the growth expectations are not met. Similarly, the Price-to-Book (PB) Ratio for Ensign Group is 4.25, again above the sector average of 2.72. This ratio compares a company's market value to its book value, and a higher ratio may imply that the stock is overpriced relative to its actual assets. Additionally, while Ensign Group boasts a strong Net Profit Margin of 5.61, this figure is juxtaposed against the sector's strikingly negative average of -145.98. This discrepancy highlights the company’s profitability, but it also raises questions about how sustainable this margin is amid rising competition and market pressures. While the company shows commendable returns on equity and assets, its relatively low Dividend Yield of 0.18 compared to the sector's 0.26 suggests that investors are receiving less in returns through dividends, which could be a red flag for income-focused investors. This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued

More Signals

Feature in Progress
This section is under development. Check back soon for updates!